Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

402
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
402
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

282
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
282
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

205
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
205
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

310
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
310
Cancer02:18

Cancer

53.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.6K
What is Cancer?02:12

What is Cancer?

14.0K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2026
Same author

2-Year Outcomes Following Transseptal Mitral Valve Replacement With the HighLife System.

JACC. Cardiovascular interventions·2026
Same author

Organ Preservation in Rectal Cancer Management: A Prospective GRECCAR Snapshot Study.

Diseases of the colon and rectum·2026
Same author

Étude de faisabilité du dispositif « Passerelle » couplant transfert monétaire non fléché et orientation sociale destiné à des ménages en situation de précarité en France.

Canadian journal of public health = Revue canadienne de sante publique·2026
Same author

ADP-dependent platelet activation is required for thrombus formation in mice exposed to simulated flight conditions.

Blood vessels, thrombosis & hemostasis·2026
Same author

Prognostic Impact of Qualitative and Quantitative Mitral Valve Calcification in Transapical Transcatheter Mitral Valve Replacement: A Sub-Analysis of the TENDER Registry.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jan 20, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.1K

Microvesicles and Cancer Associated Thrombosis.

Romaric Lacroix1,2, Loris Vallier1, Amandine Bonifay1

  • 1Aix-Marseille University, INSERM, INRA, C2VN UMR_S1263, UFR de Pharmacie, Marseille, France.

Seminars in Thrombosis and Hemostasis
|August 21, 2019
PubMed
Summary

Microvesicles (MVs) are implicated in cancer-associated thrombosis (CAT). While TF-positive MVs show promise as biomarkers in some cancers, their role requires further investigation due to complex mechanisms and methodological limitations.

More Related Videos

Paper-Based Preconcentration and Isolation of Microvesicles and Exosomes
05:26

Paper-Based Preconcentration and Isolation of Microvesicles and Exosomes

Published on: April 29, 2020

6.7K
Isolation and Characterization of Microvesicles from Peripheral Blood
06:03

Isolation and Characterization of Microvesicles from Peripheral Blood

Published on: January 6, 2017

23.7K

Related Experiment Videos

Last Updated: Jan 20, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.1K
Paper-Based Preconcentration and Isolation of Microvesicles and Exosomes
05:26

Paper-Based Preconcentration and Isolation of Microvesicles and Exosomes

Published on: April 29, 2020

6.7K
Isolation and Characterization of Microvesicles from Peripheral Blood
06:03

Isolation and Characterization of Microvesicles from Peripheral Blood

Published on: January 6, 2017

23.7K

Area of Science:

  • Extracellular Vesicles Biology
  • Oncology
  • Hemostasis and Thrombosis

Background:

  • Microvesicles (MVs) are cell-derived vesicles involved in intercellular communication.
  • Procoagulant MVs, particularly those carrying tissue factor (TF), are linked to cancer-associated thrombosis (CAT) in animal models.
  • Clinical associations between TF-positive MVs and CAT are observed in pancreatic-biliary cancers but not consistently in others.

Purpose of the Study:

  • To explore the role of microvesicles in cancer-associated thrombosis.
  • To investigate potential mechanisms and limitations in using MVs as predictive biomarkers for CAT.
  • To identify future research directions for reassessing the clinical utility of MVs in CAT.

Main Methods:

  • Review of existing literature on microvesicles, tissue factor, and cancer-associated thrombosis.
  • Analysis of proposed molecular mechanisms involving MVs in thrombosis.
  • Discussion of methodological challenges in MV measurement.

Main Results:

  • TF-positive MVs contribute to experimental CAT, with clinical associations seen in specific cancers.
  • Other molecular factors like polyphosphates and phosphatidylethanolamine may also be involved.
  • The clinical utility of MVs as CAT biomarkers is limited by diverse mechanisms, complex hemostatic roles, and measurement standardization issues.

Conclusions:

  • The role of MVs in CAT is complex and cancer-type specific.
  • Further research is needed to standardize MV measurement and elucidate their multifaceted roles in hemostasis.
  • Reassessment of MVs as clinical biomarkers for CAT requires addressing current methodological and mechanistic uncertainties.